Market Cap
$120.01 B
-$741.68 M-0.61%
Thu, 28 Nov 2024 00:25:32 GMT
Summary:
Vertex Pharmaceuticals Incorporated market capitalization is currently $120.01 billion, with a fall of -$741.68 million (-0.61%) during the most recent trading day. Over the past year, it has increased by +$29.69 billion (+32.87%). VRTX market cap is now -10.39% below its all-time high of $133.92 billion.VRTX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | -0.6% | -0.6% | -0.1% | - |
| 1 m1 month | -2.5% | -2.5% | - | - |
| 3 m3 months | -3.1% | -2.9% | - | - |
| 6 m6 months | +1.9% | +2.1% | - | - |
| ytdytd | +14.1% | +14.2% | - | - |
| 1 y1 year | +32.9% | +33.0% | -0.1% | - |
| 5 y5 years | +112.1% | +111.8% | +0.1% | - |
VRTX Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $134 B | -10.4% | $116 B | +3.5% |
| 3 m | 3 months | $134 B | -10.4% | $115 B | +4.4% |
| 6 m | 6 months | $134 B | -10.4% | $114 B | +5.7% |
| 1 y | 1 year | $134 B | -10.4% | $90 B | +34.0% |
| 3 y | 3 years | $134 B | -10.4% | $47 B | +157.1% |
| 5 y | 5 years | $134 B | -10.4% | $45 B | +164.6% |
| alltime | all time | $134 B | -10.4% | $82 M | >+9999.0% |
Vertex Pharmaceuticals Incorporated Market Cap History
| Date | Value |
|---|---|
| 2024 | $120.01 B(+14.1%) |
| 2023 | $105.17 B(+41.7%) |
| 2022 | $74.22 B(+32.8%) |
| 2021 | $55.88 B(-9.0%) |
| 2020 | $61.42 B(+8.3%) |
| 2019 | $56.71 B(+34.1%) |
| 2018 | $42.28 B(+11.4%) |
| 2017 | $37.95 B(+107.5%) |
| 2016 | $18.29 B(-41.0%) |
| 2015 | $30.99 B(+7.9%) |
| 2014 | $28.72 B(+65.3%) |
| 2013 | $17.37 B(+90.8%) |
| 2012 | $9.10 B(+31.0%) |
| 2011 | $6.95 B(-2.5%) |
| 2010 | $7.13 B(-16.8%) |
| 2009 | $8.57 B(+87.4%) |
| 2008 | $4.57 B(+48.1%) |
| Date | Value |
|---|---|
| 2007 | $3.09 B(-34.6%) |
| 2006 | $4.72 B(+57.7%) |
| 2005 | $2.99 B(+250.6%) |
| 2004 | $853.68 M(+5.7%) |
| 2003 | $807.56 M(-33.3%) |
| 2002 | $1.21 B(-34.4%) |
| 2001 | $1.85 B(-56.7%) |
| 2000 | $4.26 B(+374.1%) |
| 1999 | $898.98 M(+19.2%) |
| 1998 | $754.43 M(-9.3%) |
| 1997 | $832.13 M(-2.0%) |
| 1996 | $849.15 M(+85.2%) |
| 1995 | $458.42 M(+77.8%) |
| 1994 | $257.83 M(+14.5%) |
| 1993 | $225.22 M(+89.7%) |
| 1992 | $118.70 M(-32.0%) |
| 1991 | $174.61 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Vertex Pharmaceuticals Incorporated?
- What is VRTX market capitalization year-to-date change?
- What is Vertex Pharmaceuticals Incorporated market cap year-on-year change?
What is Vertex Pharmaceuticals Incorporated market capitalization?
The current market cap of VRTX is $120.01 B
What is the all time high market cap for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high market capitalization is $133.92 B
What is VRTX market capitalization year-to-date change?
Vertex Pharmaceuticals Incorporated market capitalization has changed by +$14.83 B (+14.10%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, VRTX market capitalization has changed by +$29.69 B (+32.87%)